Mode
Text Size
Log in / Sign up
N/A N=439 Randomized Prevention

Preventing Alcohol Exposed Pregnancy Among Urban Native Young Women: Mobile CHOICES

Alcohol Exposed Pregnancy

Enrolled (actual)
439
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Alcohol Use — 86; 82; 131; 137 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Native WYSE CHOICES (Behavioral)
Age
Pediatric, Adult · 16+ yrs
Sex
Female
Sponsor
University of Colorado, Denver
Primary completion
Feb 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Alcohol Use
71; 74; 84; 88; 63; 59
PRIMARY
Alcohol Use
71; 74; 84; 88; 63; 59
PRIMARY
Alcohol Use
71; 74; 84; 88; 63; 59
PRIMARY
Alcohol Use
71; 74; 84; 88; 63; 59
PRIMARY
Effective Contraceptive Use
146; 146; 10; 18; 62; 57
PRIMARY
Effective Contraceptive Use
146; 146; 10; 18; 62; 57
PRIMARY
Effective Contraceptive Use
146; 146; 10; 18; 62; 57
PRIMARY
Effective Contraceptive Use
146; 146; 10; 18; 62; 57

Summary

Fetal Alcohol Syndrome Disorders (FASD) result in lifelong disability and are a leading cause of preventable birth defects in the US. Urban American Indian and Alaska Native (AIAN) young women are at high risk for alcohol exposed pregnancies (AEPs) which can cause FASD. In this project, the inverstigators will test the effectiveness of a culturally adapted mobile health intervention to prevent AEP, using social media to recruit AIAN young women from urban centers across the nation.

Eligibility Criteria

Inclusion Criteria

  • Identifies as American Indian or Alaska Native (AIAN)
  • Biologically female
  • 16-20 years old
  • Not pregnant
  • Not living in tribal reservation or in an Alaska Native Village
  • Live in an urban area that is at least 50,000 in population
  • Not breastfeeding
  • Has an email account
  • Has a smart phone

Exclusion Criteria

  • Age 15 or younger, and 21 or older
  • Biologically male
  • Not AIAN
  • Pregnant or breastfeeding women
  • People who live on a tribal land or in communities with less than 50,000 in population
  • Reside in the state of Alaska (until study obtains local IRB approval)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04376346). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search